Palladin Mutation and Familial Pancreatic Cancer
Author Information
Author(s): Emily Slater, Vera Amrillaeva, Volker Fendrich, Detlef Bartsch, Julie Earl, Louis J. Vitone, John P. Neoptolemos, William Greenhalf
Primary Institution: German National Case Collection for Familial Pancreatic Cancer (FaPaCa)
Hypothesis
Does the palladin mutation contribute to familial pancreatic cancer in European families?
Conclusion
The palladin mutation was not found in European families with familial pancreatic cancer.
Supporting Evidence
- The palladin mutation was found in an American family but not in European families.
- 74 individuals from European families were sequenced for the palladin mutation.
- Diabetes incidence in the studied European families was relatively low.
Takeaway
Scientists looked for a specific gene mutation in families with pancreatic cancer in Europe but didn't find it, suggesting it might not be common there.
Methodology
Sequencing of the palladin gene locus in individuals affected by pancreatic cancer and obligate carriers.
Limitations
The study only sequenced a specific locus and may not account for other mutations.
Participant Demographics
74 individuals affected by pancreatic cancer, 14 with familial multiple mole melanoma, and 9 sporadic pancreatic cancer patients under 50.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website